Illustrative image – not actual.Aventis Pharma, a unit of French drugmaker Sanofi, is on the verge of acquiring the over-the-counter (OTC) business of Universal Medicare.
The deal is likely to be valued at about Rs 500 crore. The deal, which covers about 30 brands sold by India based Universal Medicare, is expected to be signed soon. The acquisition will enhance Sanofi's OTC business in India.
